← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinfla (TREM2) — 0.00 Kinetic Threshold Model Predicts CHIP-Mediated Clearance Req (STUB1) — 0.00 NAD+-Dependent Upregulation of MCT1 Expression to Restore Ne (SLC16A1 (MCT1)) — 0.00 LXRα-Selective Agonism to Enhance Hepatic APOE Secretion and (LXRα (NR1H3)) — 0.00 Enhancement of Astrocytic Ketone Body Production via HMGCS2 (HMGCS2) — 0.00 CD38 Inhibition to Preserve NAD+ Pools and Prevent PARP1-Med (CD38, PARP1, SIRT1/3) — 0.00 FUS-Enhanced AAV-PHP.eB Delivery for Microglial IGFBPL1 Expr (IGFBPL1) — 0.00 CRP-Mediated CCR2+ Monocyte Recruitment Drives Microglial IL (CCR2, TLR4, IL1B) — 0.00 LXRβ-Selective Agonism Enhances CYP2J2-Mediated DHA Epoxide (NR1H2 (LXRβ)) — 0.00 Rare TREM2-TYROBP pathway variants complement standard PRS b (PLCG2) — 0.00 Closed-loop transcranial focused ultrasound with adaptive AP (PVALB) — 0.00 Circulating hs-CRP as Disease-Modifying Target via Astrocyti (CRP → NLRP3 → IL-1β/IL-18) — 0.00 CCL2 Gradient Disruption via Astrocytic CXCL12 Upregulation (CXCL12) — 0.00 TBK1 Loss Drives Motor Neuron Death Through Impaired Mitopha (TBK1 → OPTN / p62 / FIP200 / mitophagy machinery) — 0.00 Dynamic Blood-Based Exosome Panel for Real-Time Neuroinflamm (CHI3L1/TREM2/NRGN) — 0.00 AD Polygenic Risk Score predicts transcriptomic aging accele (%s) — 0.00 Lentiviral-Mediated Astrocytic IGFBPL1 Expression via GFAP P (IGFBPL1) — 0.00 CSF TREM2 Fragment Ratio Integrated with Neuroinflammatory C (TREM2) — 0.00 Plasma TREM2 Ectodomain Glycosylation Patterns as Microglial (TREM2/ST6GAL1/MGAT5) — 0.00 SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 (MMP9 → nuclear import machinery (KPNA1, NUP proteins, LMNA) → TARDBP cytoplasmic mislocalization) — 0.00 Astrocytic TREM2-Like Receptor Modulation of Synaptic Streng (TREML2) — 0.00 Mitochondrial Dysfunction-Mediated Neurodegeneration in Alzh (TFAM) — 0.00 TREM2-Mediated Microglial Regulation of Oligodendrocyte Prec (TREM2) — 0.00 Microglia-Mediated Synaptic Pruning Modulation to Optimize F (CX3CR1) — 0.00 TBK1 Loss Drives Microglial Senescence-SASP to Generate MMP- (TBK1) — 0.00 Ultrasound-Responsive Liposomal Nanocarriers with Thermosens (IGFBPL1) — 0.00 Optogenetic restoration of SST interneuron-mediated dendriti (SST) — 0.00 CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab (CCR2) — 0.00 CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab (CCR2) — 0.00 TREM2-Mediated Senescent Microglial Reprogramming of Astrocy (TREM2) — 0.00
Add
|
× Network-Directed Anti-Amy × Microglial TREM2 Activati
Network-Directed Anti-Amyloid Immunotherapy · connectomics · -
Composite 0.353
Price $0.36
Evidence For 0
Evidence Against 0
Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound
Microglial TREM2 · connectomics · -
Composite 0.535
Price $0.56
Evidence For 0
Evidence Against 0
Microglial TREM2 Activation to Enhance Synaptic Pruning Regulation
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified Mechanism connectomics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 2/11
dimensions won
Network-Directed Anti-Amyloid Immunother
10/11
dimensions won
Microglial TREM2 Activation to Enhance S
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Network-Directed Anti-Amyloid Microglial TREM2 Activation to Mechanistic 0.450 0.700 Evidence 0.350 0.650 Novelty 0.800 0.750 Feasibility 0.250 0.500 Impact 0.400 0.650 Druggability 0.350 0.550 Safety 0.300 0.400 Competition 0.450 0.550 Data 0.350 0.650 Reproducible 0.350 0.400 KG Connect 0.500 0.500
Evidence Network-Directed Anti-Amyloid Immunotherapy via Transcranial No evidence citations yet
Microglial TREM2 Activation to Enhance Synaptic Pruning Regu No evidence citations yet
Debate Excerpts Network-Directed Anti-Amyloid Immunotherapy via Tr 4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Connectome Preservation in Alzheimer's Disease
## Hypothesis 1: Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound
**Description:** Tra...
Skeptic
# Critical Evaluation of Connectome Preservation Hypotheses in Alzheimer's Disease
## Overview Assessment
These seven hypotheses collectively represent a sophisticated network-level approach to AD...
Domain Expert
# Expert Evaluation: Connectome Preservation Hypotheses in Alzheimer's Disease
## Drug Development Reality Check
I will evaluate each hypothesis against practical criteria: target tractability, ch...
Synthesizer
# Connectome Preservation Hypotheses - Synthesis Analysis
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": 6,
"title": "Microglial TREM2 Activation to Enhance Synaptic Pr...
Microglial TREM2 Activation to Enhance Synaptic Pr 4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Connectome Preservation in Alzheimer's Disease
## Hypothesis 1: Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound
**Description:** Tra...
Skeptic
# Critical Evaluation of Connectome Preservation Hypotheses in Alzheimer's Disease
## Overview Assessment
These seven hypotheses collectively represent a sophisticated network-level approach to AD...
Domain Expert
# Expert Evaluation: Connectome Preservation Hypotheses in Alzheimer's Disease
## Drug Development Reality Check
I will evaluate each hypothesis against practical criteria: target tractability, ch...
Synthesizer
# Connectome Preservation Hypotheses - Synthesis Analysis
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": 6,
"title": "Microglial TREM2 Activation to Enhance Synaptic Pr...
Price History Overlay
Knowledge Graph Comparison
Network-Directed Anti-Amyloid Immunother
5 edges
Top Relations implicates_in 5
Microglial TREM2 Activation to Enhance S
5 edges
Top Relations implicates_in 5